Welcome to the Future of Therapeutic Discovery
The path from target to therapy is too slow, too expensive, and too uncertain.
We’re pioneering the infrastructure to change that—using conserved biology, whole-organism insights, and Adaptive AI to identify which therapies will translate to human outcomes.
The RapidGen™ Platform:
Fast, Scalable, In Vivo Discovery
- Whole-organism insights: Behavior, morphology, transcriptomics, proteomics
- AI-powered prioritization: Focus resources on high-potential leads early
- Rapid Results: Decision-driving data in weeks, not months
Trusted by Innovators Across Biotech & Academia
With hundreds of clients and a proven track record of preclinical studies, InVivo Biosystems delivers the expertise and technology to accelerate therapeutic discovery.
400+ Clients Served
Trusted for precision & quality
600+ Studies Delivered
Fast, reliable research at scale
10+ Patents Issued
Collaborative innovation in action
Translational Tools for Real-World Biology
We combine advanced genetic tools with whole-organism models to deliver high-throughput, translatable insights.
Our technologies accelerate preclinical research by bridging conserved biology and real-world complexity.
- High-Throughput In Vivo Screening
- AI-Driven Data Integration
- Multi-Omics Readouts at Organism Scale
Zebrafish Models
A powerful vertebrate system for studying human disease, drug response, and developmental biology.
- Real-time, whole-organism visualization of gene function
- High-throughput screening for efficacy, safety, and MoA
- Strong conservation with human genetics for better translation
C. elegans Models
A proven platform for studying aging, neurobiology, and rare disease modeling.
- Ideal for modeling conserved pathways in neurodegeneration
- Fast life cycle for rapid hypothesis testing
- High-throughput genetic screening
Ready to Get Started?
Let’s explore what we can discover together.
Contact Us
Let’s build the future of discovery together.